Norinchukin Bank’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$937K Buy
10,361
+20
+0.2% +$1.83K 0.01% 451
2025
Q4
$930K Buy
10,341
+341
+3% +$32.3K 0.01% 453
2025
Q3
$985K Buy
10,000
+395
+4% +$39.1K 0.01% 431
2025
Q2
$876K Buy
9,605
+625
+7% +$60.4K 0.01% 434
2025
Q1
$1.02M Buy
8,980
+1,020
+13% +$109K 0.02% 385
2024
Q4
$841K Buy
7,960
+40
+0.5% +$4.29K 0.02% 396
2024
Q3
$855K Buy
7,920
+858
+12% +$93.6K 0.02% 377
2024
Q2
$766K Sell
7,062
-205
-3% -$24.2K 0.02% 347
2024
Q1
$959K Sell
7,267
-100
-1% -$12.5K 0.03% 309
2023
Q4
$897K Sell
7,367
-754
-9% -$84.1K 0.02% 313
2023
Q3
$911K Sell
8,121
-9,533
-54% -$1.21M 0.02% 308
2023
Q2
$2.57M Buy
17,654
+4,525
+34% +$615K 0.04% 267
2023
Q1
$1.7M Buy
13,129
+412
+3% +$51.7K 0.03% 282
2022
Q4
$1.62M Sell
12,717
-2,805
-18% -$326K 0.03% 280
2022
Q3
$1.62M Buy
15,522
+1,636
+12% +$180K 0.03% 294
2022
Q2
$1.46M Sell
13,886
-5,401
-28% -$641K 0.03% 299
2022
Q1
$2.47M Buy
19,287
+886
+5% +$107K 0.03% 286
2021
Q4
$2.27M Sell
18,401
-105
-0.6% -$13.7K 0.03% 289
2021
Q3
$2.63M Buy
18,506
+738
+4% +$109K 0.04% 247
2021
Q2
$2.77M Sell
17,768
-5
-0% -$810 0.04% 226
2021
Q1
$2.76M Buy
17,773
+300
+2% +$46.5K 0.04% 217
2020
Q4
$2.61M Sell
17,473
-408
-2% -$57.6K 0.04% 207
2020
Q3
$2.36M Buy
17,881
+241
+1% +$31.5K 0.04% 196
2020
Q2
$2.04M Sell
17,640
-90
-0.5% -$10.4K 0.03% 214
2020
Q1
$1.74M Sell
17,730
-10,315
-37% -$1.35M 0.03% 204
2019
Q4
$4.08M Sell
28,045
-2,477
-8% -$342K 0.05% 192
2019
Q3
$4.07M Buy
30,522
+814
+3% +$105K 0.06% 199
2019
Q2
$3.4M Sell
29,708
-10,256
-26% -$1.2M 0.05% 226
2019
Q1
$4.96M Buy
39,964
+1,477
+4% +$168K 0.06% 195
2018
Q4
$3.88M Buy
38,487
+11,529
+43% +$1.3M 0.05% 215
2018
Q3
$3.44M Buy
26,958
+3,235
+14% +$385K 0.05% 202
2018
Q2
$2.57M Buy
23,723
+4,551
+24% +$495K 0.04% 230
2018
Q1
$2.03M Buy
19,172
+2,499
+15% +$290K 0.03% 244
2017
Q4
$1.95M Buy
16,673
+1,171
+8% +$132K 0.03% 242
2017
Q3
$1.76M Buy
15,502
+1,120
+8% +$129K 0.03% 278
2017
Q2
$1.79M Buy
14,382
+922
+7% +$109K 0.04% 266
2017
Q1
$1.6M Buy
13,460
+943
+8% +$107K 0.03% 278
2016
Q4
$1.25M Buy
12,517
+1,488
+13% +$159K 0.03% 292
2016
Q3
$1.39M Buy
11,029
+493
+5% +$60.9K 0.03% 268
2016
Q2
$1.23M Buy
10,536
+1,078
+11% +$122K 0.03% 266
2016
Q1
$979K Buy
9,458
+1,220
+15% +$118K 0.02% 308
2015
Q4
$821K Sell
8,238
-1,828
-18% -$179K 0.02% 313
2015
Q3
$918K Buy
10,066
+130
+1% +$13K 0.02% 325
2015
Q2
$1.05M Sell
9,936
-440
-4% -$48.7K 0.03% 314
2015
Q1
$1.18M Buy
10,376
+97
+0.9% +$11.1K 0.03% 304
2014
Q4
$1.13M Buy
10,279
+3,294
+47% +$347K 0.03% 309
2014
Q3
$682K Buy
6,985
+535
+8% +$52.6K 0.02% 274
2014
Q2
$650K Sell
6,450
-767
-11% -$74.8K 0.02% 252
2014
Q1
$663K Buy
7,217
+639
+10% +$58.9K 0.02% 266
2013
Q4
$595K Buy
6,578
+18
+0.3% +$1.56K 0.02% 268
2013
Q3
$523K Buy
6,560
+554
+9% +$43.6K 0.02% 279
2013
Q2
$437K Buy
+6,006
New +$449K 0.01% 279

Other funds holding ZBH

Norinchukin Bank's ZBH Position: Q1 2026 in Review

Norinchukin Bank increased its Zimmer Biomet (ZBH) stake by 0.19% in Q1 2026, buying an estimated $1.83K and bringing the position to 10,361 shares worth $937K. The position accounts for 0.01% of the portfolio, ranked #451.

Norinchukin Bank first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.96M in Q1 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Norinchukin Bank held 10,361 shares of Zimmer Biomet worth $937K as of Q1 2026.
  • Norinchukin Bank bought 20 Zimmer Biomet shares in Q1 2026, an estimated $1.83K.
  • Zimmer Biomet made up 0.01% of Norinchukin Bank's portfolio in Q1 2026, its #451 holding.
  • Norinchukin Bank first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Norinchukin Bank's Zimmer Biomet position peaked at $4.96M in Q1 2019.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.